Review



human acc cell line sw13  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC human acc cell line sw13
    Flow diagram of patient inclusion, signature construction, and validation in <t>ACC</t> cohorts. A schematic overview of the study design including sample screening, inclusion, and analytical stages. Adrenocortical carcinoma (ACC) patients from three independent cohorts – The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and West China Hospital (WCH) – were assessed. After applying exclusion criteria, final cohorts included TCGA ( n = 79), GEO ( n = 24), and WCH ( n = 78). A transcription factor-based prognostic signature involving ATF/CREB family genes was constructed using Cox and LASSO Cox regression in the TCGA training cohort. The model’s prognostic and immunological significance was analyzed. External validation was performed in GEO ( GSE10927 ) and WCH cohorts, with further functional assays in <t>SW13</t> cell line.
    Human Acc Cell Line Sw13, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 337 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human acc cell line sw13/product/ATCC
    Average 96 stars, based on 337 article reviews
    human acc cell line sw13 - by Bioz Stars, 2026-06
    96/100 stars

    Images

    1) Product Images from "Comprehensive analysis of an ATF/CREB family-based signature with regard to prognosis and immune feature in adrenocortical carcinoma: a cohort study"

    Article Title: Comprehensive analysis of an ATF/CREB family-based signature with regard to prognosis and immune feature in adrenocortical carcinoma: a cohort study

    Journal: International Journal of Surgery (London, England)

    doi: 10.1097/JS9.0000000000002961

    Flow diagram of patient inclusion, signature construction, and validation in ACC cohorts. A schematic overview of the study design including sample screening, inclusion, and analytical stages. Adrenocortical carcinoma (ACC) patients from three independent cohorts – The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and West China Hospital (WCH) – were assessed. After applying exclusion criteria, final cohorts included TCGA ( n = 79), GEO ( n = 24), and WCH ( n = 78). A transcription factor-based prognostic signature involving ATF/CREB family genes was constructed using Cox and LASSO Cox regression in the TCGA training cohort. The model’s prognostic and immunological significance was analyzed. External validation was performed in GEO ( GSE10927 ) and WCH cohorts, with further functional assays in SW13 cell line.
    Figure Legend Snippet: Flow diagram of patient inclusion, signature construction, and validation in ACC cohorts. A schematic overview of the study design including sample screening, inclusion, and analytical stages. Adrenocortical carcinoma (ACC) patients from three independent cohorts – The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and West China Hospital (WCH) – were assessed. After applying exclusion criteria, final cohorts included TCGA ( n = 79), GEO ( n = 24), and WCH ( n = 78). A transcription factor-based prognostic signature involving ATF/CREB family genes was constructed using Cox and LASSO Cox regression in the TCGA training cohort. The model’s prognostic and immunological significance was analyzed. External validation was performed in GEO ( GSE10927 ) and WCH cohorts, with further functional assays in SW13 cell line.

    Techniques Used: Biomarker Discovery, Gene Expression, Construct, Functional Assay



    Similar Products

    96
    ATCC human acc cell line sw13
    Flow diagram of patient inclusion, signature construction, and validation in <t>ACC</t> cohorts. A schematic overview of the study design including sample screening, inclusion, and analytical stages. Adrenocortical carcinoma (ACC) patients from three independent cohorts – The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and West China Hospital (WCH) – were assessed. After applying exclusion criteria, final cohorts included TCGA ( n = 79), GEO ( n = 24), and WCH ( n = 78). A transcription factor-based prognostic signature involving ATF/CREB family genes was constructed using Cox and LASSO Cox regression in the TCGA training cohort. The model’s prognostic and immunological significance was analyzed. External validation was performed in GEO ( GSE10927 ) and WCH cohorts, with further functional assays in <t>SW13</t> cell line.
    Human Acc Cell Line Sw13, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human acc cell line sw13/product/ATCC
    Average 96 stars, based on 1 article reviews
    human acc cell line sw13 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    96
    ATCC sw13 human acc cell lines
    Flow diagram of patient inclusion, signature construction, and validation in <t>ACC</t> cohorts. A schematic overview of the study design including sample screening, inclusion, and analytical stages. Adrenocortical carcinoma (ACC) patients from three independent cohorts – The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and West China Hospital (WCH) – were assessed. After applying exclusion criteria, final cohorts included TCGA ( n = 79), GEO ( n = 24), and WCH ( n = 78). A transcription factor-based prognostic signature involving ATF/CREB family genes was constructed using Cox and LASSO Cox regression in the TCGA training cohort. The model’s prognostic and immunological significance was analyzed. External validation was performed in GEO ( GSE10927 ) and WCH cohorts, with further functional assays in <t>SW13</t> cell line.
    Sw13 Human Acc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sw13 human acc cell lines/product/ATCC
    Average 96 stars, based on 1 article reviews
    sw13 human acc cell lines - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    96
    ATCC human acc cell lines sw13
    Flow diagram of patient inclusion, signature construction, and validation in <t>ACC</t> cohorts. A schematic overview of the study design including sample screening, inclusion, and analytical stages. Adrenocortical carcinoma (ACC) patients from three independent cohorts – The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and West China Hospital (WCH) – were assessed. After applying exclusion criteria, final cohorts included TCGA ( n = 79), GEO ( n = 24), and WCH ( n = 78). A transcription factor-based prognostic signature involving ATF/CREB family genes was constructed using Cox and LASSO Cox regression in the TCGA training cohort. The model’s prognostic and immunological significance was analyzed. External validation was performed in GEO ( GSE10927 ) and WCH cohorts, with further functional assays in <t>SW13</t> cell line.
    Human Acc Cell Lines Sw13, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human acc cell lines sw13/product/ATCC
    Average 96 stars, based on 1 article reviews
    human acc cell lines sw13 - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    Image Search Results


    Flow diagram of patient inclusion, signature construction, and validation in ACC cohorts. A schematic overview of the study design including sample screening, inclusion, and analytical stages. Adrenocortical carcinoma (ACC) patients from three independent cohorts – The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and West China Hospital (WCH) – were assessed. After applying exclusion criteria, final cohorts included TCGA ( n = 79), GEO ( n = 24), and WCH ( n = 78). A transcription factor-based prognostic signature involving ATF/CREB family genes was constructed using Cox and LASSO Cox regression in the TCGA training cohort. The model’s prognostic and immunological significance was analyzed. External validation was performed in GEO ( GSE10927 ) and WCH cohorts, with further functional assays in SW13 cell line.

    Journal: International Journal of Surgery (London, England)

    Article Title: Comprehensive analysis of an ATF/CREB family-based signature with regard to prognosis and immune feature in adrenocortical carcinoma: a cohort study

    doi: 10.1097/JS9.0000000000002961

    Figure Lengend Snippet: Flow diagram of patient inclusion, signature construction, and validation in ACC cohorts. A schematic overview of the study design including sample screening, inclusion, and analytical stages. Adrenocortical carcinoma (ACC) patients from three independent cohorts – The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and West China Hospital (WCH) – were assessed. After applying exclusion criteria, final cohorts included TCGA ( n = 79), GEO ( n = 24), and WCH ( n = 78). A transcription factor-based prognostic signature involving ATF/CREB family genes was constructed using Cox and LASSO Cox regression in the TCGA training cohort. The model’s prognostic and immunological significance was analyzed. External validation was performed in GEO ( GSE10927 ) and WCH cohorts, with further functional assays in SW13 cell line.

    Article Snippet: The human ACC cell line SW13 was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA).

    Techniques: Biomarker Discovery, Gene Expression, Construct, Functional Assay